/r/LungCancerSupport

Year:

Only show posts with narrations

Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.

1 upvotes • WalkingHorse

Mark as read: Add to a list

Targeted degradation of KRAS protein in non-small cell lung cancer: Therapeutic strategies using liposomal PROTACs with enhanced cellular uptake and pharmacokinetic profiles

1 upvotes • WalkingHorse

Mark as read: Add to a list

Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non–small-cell lung cancer | Journal of Translational Medicine

1 upvotes • WalkingHorse

Mark as read: Add to a list

Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature | BMC Medical Imaging

1 upvotes • WalkingHorse

Mark as read: Add to a list

The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer | BMC Cancer

1 upvotes • WalkingHorse

Mark as read: Add to a list

MicroRNA-522-3p promotes brain metastasis in non-small cell lung cancer by targeting Tensin 1 and modulating blood-brain barrier permeability

1 upvotes • WalkingHorse

Mark as read: Add to a list

Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer

1 upvotes • WalkingHorse

Mark as read: Add to a list

Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC | The Oncologist

1 upvotes • WalkingHorse

Mark as read: Add to a list

Optimum timing of lung resection surgery following SARS-CoV-2 infection for non-small cell lung cancer

1 upvotes • WalkingHorse

Mark as read: Add to a list

Incidence and risk factors of immune-related adverse events induced by immune checkpoint inhibitors among older adults with non-small cell lung cancer

1 upvotes • WalkingHorse

Mark as read: Add to a list

Title	Upvotes	Author	Mark as read	Favorited	Rating	Add to a list
Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.	1	WalkingHorse
Targeted degradation of KRAS protein in non-small cell lung cancer: Therapeutic strategies using liposomal PROTACs with enhanced cellular uptake and pharmacokinetic profiles	1	WalkingHorse
Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non–small-cell lung cancer \| Journal of Translational Medicine	1	WalkingHorse
Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature \| BMC Medical Imaging	1	WalkingHorse
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer \| BMC Cancer	1	WalkingHorse
MicroRNA-522-3p promotes brain metastasis in non-small cell lung cancer by targeting Tensin 1 and modulating blood-brain barrier permeability	1	WalkingHorse
Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer	1	WalkingHorse
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC \| The Oncologist	1	WalkingHorse
Optimum timing of lung resection surgery following SARS-CoV-2 infection for non-small cell lung cancer	1	WalkingHorse
Incidence and risk factors of immune-related adverse events induced by immune checkpoint inhibitors among older adults with non-small cell lung cancer	1	WalkingHorse